| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.17 | 0.002 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.09 | 0.002 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.099 | 0.003 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.098 | 0.003 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.003 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.092 | 0.003 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.003 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.097 | 0.003 |